Iowa StARR Scholars Program
爱荷华州 StarR 学者计划
基本信息
- 批准号:10565958
- 负责人:
- 金额:$ 32.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAddressAreaAwardBasic ScienceBiologyCardiovascular DiseasesCardiovascular systemCareer ChoiceChildhoodClinicalClinical ResearchClinical SciencesClinical SkillsCommunications MediaCompetenceDevelopmentDevelopment PlansEducationEligibility DeterminationEnsureEnvironmentFacultyFellowshipFundingFutureGoalsHematological DiseaseHematologyImmersionIndividualInternal MedicineInternationalIowaLeadershipLungLung diseasesManuscriptsMedicalMedicineMentorsNational Heart, Lung, and Blood InstituteOralPathway interactionsPediatricsPhysiciansPopulationPositioning AttributePreparationPublicationsRecording of previous eventsResearchResearch TrainingResidenciesResourcesScholars ProgramScientistSleepSleep DisordersSlideTrainingTraining ProgramsTranslational ResearchUnited StatesUnited States National Institutes of HealthUniversitiesWritingcareercareer developmentcollegedesignexperienceimaging facilitiesinnovationinterestlung imagingmeetingspostersprogramsrecruitrole modelskillssuccesssymposiumtimeline
项目摘要
PROJECT SUMMARY
The Iowa StARR Scholars Program is designed to help address the continuing need for physician-scientists in
the fields of internal medicine and pediatrics. The University of Iowa Carver College of Medicine (CCOM) has an
outstanding group of physician-scientists, a tradition of training physician-scientists, and a long history of
physician-scientist leadership. The Iowa StARR Scholars Program will identify residents early in their training
who have an interest in a mentored research experience during their residency. The Specific Aims of the
program include: Aim 1. To recruit and train outstanding Scholars from the University of Iowa internal
medicine and pediatric residency programs to increase the pipeline of physician-scientists. Aim 2. To create
an academic environment that stimulates and encourages promising trainees toward a career path as a
physician-scientist. Aim 3. To provide a highly focused and mentored research experience in the areas of
cardiovascular, lung, blood, and sleep diseases that promotes the Scholar’s success. Aim 4. To develop a
personalized mentoring and career development plan for each StARR Scholar that ensures mastery of
clinical skills and outstanding training and development as a scientist. Aim 5. To provide guidance and advice
for subsequent subspecialty fellowship training. We will focus on trainees who may not have otherwise
considered a career as a physician-scientist, and will provide them with the opportunities, mentoring, and skills
they need to succeed. This will be accomplished through a positive mentored research experience over 12-18
months in the context of their residency. Subsequent to this program, we anticipate that trainees will pursue
subspecialty training with a research focus and pursue research-oriented independent careers in academic
medical centers. We identified a team of outstanding, diverse, accomplished mentors in basic, translational, and
clinical research responsive to NHLBI priorities. The Iowa StARR Scholars Program will provide an environment
conducive to success. Key features include: 1) a mentored research experience that promotes the Scholars’
success and enthusiasm for a career as a physician-scientist. This includes immersion in a rich research
environment with interactions with successful physician-scientists; 2) an individual development plan designed
around the trainee’s experience and career goals and supervised by a mentoring committee; 3) regular
assessment of research competencies; 4) training in forms of communication including slide preparation,
planning of scientific talks, presentations at regional and national meetings, and manuscript writing and
publication; 5) a range of program activities including selected coursework, conferences and symposia, designed
to enrich the research experience and provide context for future success. At the completion of the program Iowa
StARR Scholars should have the clinical and research backgrounds needed to attain board eligibility in pediatrics
or internal medicine, succeed in subspecialty training, pursue support via the K38 program, and advance to
faculty positions aimed at independent research careers.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL B MCCRAY其他文献
PAUL B MCCRAY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL B MCCRAY', 18)}}的其他基金
Molecular Therapies for Cystic Fibrosis Lung Disease
囊性纤维化肺病的分子疗法
- 批准号:
10470331 - 财政年份:2020
- 资助金额:
$ 32.24万 - 项目类别:
Molecular Therapies for Cystic Fibrosis Lung Disease
囊性纤维化肺病的分子疗法
- 批准号:
10677580 - 财政年份:2020
- 资助金额:
$ 32.24万 - 项目类别:
Gene Editing Strategies to Correct CFTR Mutations
纠正 CFTR 突变的基因编辑策略
- 批准号:
10024666 - 财政年份:2020
- 资助金额:
$ 32.24万 - 项目类别:
Gene Editing Strategies to Correct CFTR Mutations
纠正 CFTR 突变的基因编辑策略
- 批准号:
10677600 - 财政年份:2020
- 资助金额:
$ 32.24万 - 项目类别:
Molecular Therapies for Cystic Fibrosis Lung Disease
囊性纤维化肺病的分子疗法
- 批准号:
10024661 - 财政年份:2020
- 资助金额:
$ 32.24万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 32.24万 - 项目类别:
Research Grant














{{item.name}}会员




